gyy-4137 has been researched along with Infant--Newborn--Diseases* in 1 studies
1 other study(ies) available for gyy-4137 and Infant--Newborn--Diseases
| Article | Year |
|---|---|
Hydrogen Sulfide Improves Outcomes in a Murine Model of Necrotizing Enterocolitis via the Cys440 Residue on Endothelial Nitric Oxide Synthase.
Hydrogen sulfide (H. In WT mice, the administration of GYY4137 significantly improved clinical sickness scores, attenuated intestinal and lung injury, and improved mesenteric perfusion compared to vehicle (p < 0.05). In eNOS. GYY4137 administration improves clinical outcomes, attenuates intestinal and lung injury, and improves perfusion in a murine model of necrotizing enterocolitis. The beneficial effects of GYY4137 are dependent on the Cys440 residue of eNOS. Topics: Animals; Disease Models, Animal; Enterocolitis, Necrotizing; Humans; Hydrogen Sulfide; Infant, Newborn; Infant, Newborn, Diseases; Lung Injury; Mice; Nitric Oxide; Nitric Oxide Synthase Type III | 2023 |